← Open Payments lookup

UMARU LABAY-KAMARA: Open Payments

NPI 1396907945 · HUGHESVILLE, MD. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$1,691 in 74 payments from 11 companies in 2025. Trend: 2023 $1,335 · 2024 $1,435 · 2025 $1,691

Food & beverage: $1,688Education: $4
CompanyPaymentsAmount
ABBVIE INC.28$364
Neurocrine BioSciences, Inc.4$294
Otsuka America Pharmaceutical, Inc.9$244
E.R. Squibb & Sons, L.L.C.6$226
Alkermes, Inc.13$193
Teva Pharmaceuticals USA, Inc.5$107
Vanda Pharmaceuticals Inc.3$95
Janssen Pharmaceuticals, Inc2$81
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)2$44
Supernus Pharmaceuticals, Inc.1$25

Products named: VRAYLAR, INGREZZA, ABILIFY ASIMTUFII, BREYANZI, REXULTI, ARISTADA, FANAPT, COBENFY.

Industry payments across MD — which companies pay providers there.